University of Regensburg   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Regensburg Germany (1962)

Organization Overview

First Clinical Trial
2002
NCT00944801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Berthold Langguth, MD, Ph.D. | Department of Neurology, University of Regensburg | Department of Obstetrics and Gynaecology, University of Regensburg, Germany | Department of Surgery, University Medical Center Regensburg | Dept. of Ophthalmology, University of Regensburg | Donauspital KH SMZ Ost, Neurologie | Edward Geissler | Institue for Medical Microbiology, University of Regensburg | Prof. Dr. Berthold Schalke | Psychosoziale Begleitung - Praxis Boniakowski, Regensburg | Regensburg University | Regensburg University Hospital | Regensburg University Hospital Department of Surgery | Regensburg University Hospital, Department of Surgery | Regensburg University Medical Center, Department of Surgery | Regensburg University Medical Center, Director of Surgical Department | Regensburg University Medical Center, Head of Experimental Surgery | Universitat Regensburg | University Hospital of Regensburg | University Hospital Regensburg | University Hospital Regensburg, University of Regensburg | University of Regensburg | University of Regensburg, Department of Pediatric Hematology and Oncology | University of Regensburg, Dept. of Neurology, Germany